logo-loader
viewBankrate

Bankrate trading at discount to initial IPO listing price

stock_market_350_4dfb9af1e4699.jpg

Personal finance website Bankrate (NYSE:RATE) opened down by more than 6% on its first day of public trading on the New York Stock Exchange, and is now currently trading at a near 2% discount to its initial listing price.

The company, which listed 20.0 million shares of its common stock at $15.00 per share, provides comparative rate information on more than 300 financial products, including mortgages, insurance, credit cards, bank deposits and car loans. As of Friday just after 2:00pm EST, its shares were currently trading at around $14.73.

The expected price range for the offering was between $14 to $16 per share. Bankrate sold 12.5 million shares, while selling stockholders offered up 7.5 million shares. In addition, underwriters were granted a 30-day option to purchase up to 3.0 million additional shares from the selling stockholders at the $15 per share price.

Florida-based Bankrate, which moved onling in 2006, was acquired in August 2009 by buyout giant Apax Partners after being public company for ten years.

Since Apax acquired the company, Bankrate has bulked up its business and made several asset purchases, including CreditCards.com, with both revenue and operating income steadily on the rise. However, the company is still saddled with a debt burden of nearly $300 million.

In the first quarter, Bankrate reported revenue of $99.1 million, almost triple from a year earlier, while it swung to a profit of $5.1 million, up from a net loss of $5.2 million in the prior year period. The company's operations are highly dependent on the state of the economy, as Bankrate itself warned that a decrease in mortgage production volumes could negatively impact its business.

The joint bookrunning managers for the offering were Goldman Sachs and BofA Merrill Lynch.

Quick facts: Bankrate

Price: - -

NYSE:RATE
Market: NYSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks back in the red but make gains overall...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, sank 4.4% at 123 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 5.8% to C$9.55, while the OTCQX Cannabis retreated 4% at...

2 hours, 43 minutes ago

2 min read